Michael Scolaro

Michael Scolaro

Sep 01, 2017

Group 6 Copy 123
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    What is the role of the CLN1-CDK1 complex in the cell regulatory cycle of baker's yeast?

    In Saccharomyces cerevisiae, the protein CLN1 forms a complex with the CDK1 in the cell regulatory cycle. Studies...

    Backer Badge Funded